Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus.
about
Pharmacokinetics, oral bioavailability, and metabolism in mice and cynomolgus monkeys of (2'R,5'S-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, an agent active against human immunodeficiency virus and human hepatitis B virusEmtricitabine (FTC) for the treatment of HIV infection.Emtricitabine, a new antiretroviral agent with activity against HIV and hepatitis B virus.Validity Study of a Jump Mat Compared to the Reference Standard Force Plate.In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks.Directly coupled HPLC-NMR and its application to drug metabolism.Safety, pharmacokinetics, and efficacy of (+/-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine with efavirenz and stavudine in antiretroviral-naïve human immunodeficiency virus-infected patients.Hplc-nmr identification of the human urinary metabolites of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analogue active against human immunodeficiency virus (HIV).Comparative pharmacokinetics of Racivir, (+/-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine in rats, rabbits, dogs, monkeys and HIV-infected humans.
P2860
Q28368057-BBB6C950-E3BA-4E73-807F-F2774FF46B81Q35810472-E88E6A5C-F07A-42F8-8CB8-616AF098F57DQ36328961-8721842C-AB50-4F04-B0B5-B558E6277A47Q36404682-F795031C-CDE0-4EE9-B603-CCF5F82EBC49Q39784993-BB85DAB4-2BC2-42B8-A115-31883CF89062Q41569984-1691EEB6-331B-4298-A716-DFE1F5C46145Q42588286-E07BFDEE-B687-44A7-9939-23E0CC37768FQ45767323-D21F1814-C8E7-48DA-843B-B1F2F5A4E5B9Q46486796-7CCB6676-B25D-4286-82C6-ACCC24A47925
P2860
Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Pharmacokinetics, oral bioavai ...... y virus and hepatitis B virus.
@en
type
label
Pharmacokinetics, oral bioavai ...... y virus and hepatitis B virus.
@en
prefLabel
Pharmacokinetics, oral bioavai ...... y virus and hepatitis B virus.
@en
P2093
P2860
P356
P1476
Pharmacokinetics, oral bioavai ...... y virus and hepatitis B virus.
@en
P2093
Furfine ES
Painter GR
P2860
P304
P356
10.1128/AAC.37.11.2285
P407
P577
1993-11-01T00:00:00Z